Alzheimer's disease--an independent disease or a psychopathological syndrome?
Bergener, M.
Fortschritte der Medizin 98(26-27): 1001-1007
1980
ISSN/ISBN: 0015-8178 PMID: 7429384 Document Number: 156100
Document emailed within 1 workday
Related Documents
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96Mauri, M.C.; Bravin, S.; Fabiano, L.; Invernizzi, G. 1995: Effects of psychopathological components of the onset of Alzheimer's disease Minerva Psichiatrica 36(4): 203-207
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44
Albert, M.S. 1992: Parallels between down syndrome dementia and Alzheimer's disease Progress in Clinical and Biological Research 379: 77-102
García-Lara, J.M.A.; Aguilar-Navarro, S.; Gutiérrez-Robledo, L.M.; Avila-Funes, J.é A. 2010: The metabolic syndrome, diabetes, and Alzheimer's disease Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(4): 343-349
Waldman, H.B.; Perlman, S.P.; Roesch, R.E. 2008: Down syndrome and Alzheimer's disease: children grow older General Dentistry 56(5): 420-422
Lechevalier, B.; Brandel, J.P.; Eustache, F.; Schupp, C.; Chapon, F.; Viader, F. 1988: Alzheimer's disease with early association of a hemi-parkinsonian syndrome Revue Neurologique (Paris) 144(8-9): 508-511
Lara, H.Herman.; Alanís-Garza, E.Javier.; Estrada Puente, Mía.Fernanda.; Mureyko, Lía.Liliana.; Alarcón Torres, D.Alejandro.; Ixtepan Turrent, L. 2015: Nutritional approaches to modulate oxidative stress that induce Alzheimer's disease. Nutritional approaches to prevent Alzheimer's disease Gaceta Medica de Mexico 151(2): 245-251
Rosales-Reynoso, M.ón.A.; Ochoa-Hernández, A.B.; Juárez-Vázquez, C.I.; Barros-Núñez, P. 2012: Alzheimer's disease and fragile X syndrome: the Wnt/ß-catenin pathway as a common biological mechanism Revista de Neurologia 55(9): 543-548
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484
Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1996: New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease Journal of Neural Transmission. Supplementum 48: 1-6
Andrieu, S.; Rascol, O.; Lang, T.; Grandjean, H.; Vellas, B. 2006: Disease modifying trials in Alzheimer disease: methodological and statistical issues Journal of Nutrition Health and Aging 10(2): 116-117
Katz, P.R.; Chutkow, J.G. 1986: Dementia, myoclonus, and EEG findings typical of Jakob-Creutzfeldt disease in a patient with Alzheimer's disease New York State Journal of Medicine 86(3): 157-158